Skip to main content
Ocumension Therapeutics logo

Ocumension Therapeutics — Investor Relations & Filings

Ticker · 1477 ISIN · KYG674111011 LEI · 5493000USURI3SIL4Z85 HKEX Manufacturing
Open in API
Filings indexed 459 across all filing types
Latest filing 2025-06-05 Share Issue/Capital Cha…
Country KY Cayman Islands
Listing HKEX 1477

About Ocumension Therapeutics

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company dedicated to the research, development, and commercialization of first-in-class or best-in-class therapeutics. The company focuses on providing comprehensive treatment solutions for Chinese patients suffering from ocular diseases. Ocumension has established a complete ophthalmic drug product line, currently holding 20 drug assets covering both anterior and posterior segments of the eye. Its portfolio addresses major conditions such as chronic non-infectious uveitis, infective and allergic conjunctivitis, and diabetic macular edema. The company employs a strategy combining continuous scientific innovation, independent R&D, and strategic alliances to sustain the supply of innovative products across the ophthalmology field.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2025
Share Issue/Capital Change Classification · 85% confidence The document is a Hong Kong Exchange (“HKEX”) FF301 Monthly Return for movements in securities under Chapter 19B of the Listing Rules. It details changes in authorized and issued share capital, movements in issued shares and treasury shares, share option schemes, warrants, convertible and other share arrangements, and share repurchases. These are all capital structure changes (new share issues, treasury movements, repurchases), matching “Share Issue/Capital Change.” It is not an earnings release, annual/interim report, voting results, management change, or simple repurchase notice. Therefore the most precise category is SHA (Share Issue/Capital Change).
2025-06-05 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 98% confidence The document is a Hong Kong Stock Exchange Next Day Disclosure Return (Form FF305) detailing changes in issued and treasury shares, including the repurchase of 45,000 ordinary shares by the issuer. It provides a repurchase report (Section II) and confirms compliance with listing rules for share buybacks. This is a classic Transaction in Own Shares filing under our taxonomy.
2025-05-15 English
VOLUNTARY ANNOUNCEMENT OT-703 APPROVED FOR REAL WORLD STUDY IN HAINAN BOAO
Regulatory Filings Classification · 85% confidence The document is a voluntary announcement by a Hong Kong-listed company regarding the regulatory approval of its product for a real world study in Hainan Boao. It does not present financial results, governance changes, shareholder votes, dividends, M&A activity, or an actual report. It is a general corporate/regulatory update that does not fit any specific category, making “Regulatory Filings” (RNS) the appropriate fallback classification.
2025-05-13 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a "Next Day Disclosure Return" under Hong Kong listing rules (Main Board Rule 13.25A/GEM Rule 17.27A) detailing share repurchases and on-market sales of treasury shares by the issuer. It discloses changes in issued shares, treasury shares and provides a repurchase report. This is not a full financial report but a specific transaction disclosure of the company’s own shares. According to the classification definitions, this falls squarely under "Transaction in Own Shares" (Code: POS).
2025-05-12 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 92% confidence The document is a regulatory disclosure under the Hong Kong Stock Exchange Listing Rules (Main Board Rule 13.25A/GEM Rule 17.27A and Main Board Rule 10.06/GEM Rule 13.13) reporting changes in issued shares and an on-market share repurchase. It contains detailed share buyback figures, treasury share movements, repurchase prices and confirmations by the issuer. This aligns with the “Transaction in Own Shares” category.
2025-05-09 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 92% confidence The document is a regulatory "Next Day Disclosure Return" under HKEX rules 13.25A/17.27A and 10.06/13.13. It details changes in issued shares and treasury shares, specifically a repurchase of 211,000 shares held as treasury shares, including trading date, price, aggregate price paid, and mandate details. This is a report of the company buying back its own shares. This clearly falls under Transaction in Own Shares, not an annual or interim report, dividend notice, or AGM filing.
2025-05-08 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.